Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis NorovirusInterventions: Other: Placebo; Biological: Snow Mountain stool filtrateSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis NorovirusInterventions: Biological: Snow Mountain stool filtrate; Other: PlaceboSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis NorovirusInterventions: Other: Placebo; Biological: Snow Mountain stool filtrateSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis NorovirusInterventions: Biological: Snow Mountain stool filtrate; Other: PlaceboSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis NorovirusInterventions: Other: Placebo; Biological: Snow Mountain stool filtrateSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials
Optimal Human Dose for GII.2 Norovirus (Snow Mountain) Challenge Studies
Condition: Gastroenteritis NorovirusInterventions: Biological: Snow Mountain stool filtrate; Other: PlaceboSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 4, 2015 Category: Research Source Type: clinical trials
Serologic Assay Validation, Proficiency Testing Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine
Condition: NorovirusIntervention: Biological: NoV GI.1/GII.4 Bivalent VLP VaccineSponsor: TakedaActive, not recruiting - verified June 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2015 Category: Research Source Type: clinical trials